Antiaging Quantum Living files Form 12b-25 notice

Antiaging Quantum Living Inc. notified the SEC that it could not timely file its Annual Report on Form 10-K for the fiscal year ended March 31, 2026 by the June 29, 2026 due date due to a delay completing the Annual Report's financial statements.

Accepted by SEC EDGAR 06/29/2026 - 05:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Antiaging Quantum Living Inc. notified the SEC that it could not timely file its Annual Report on Form 10-K for the fiscal year ended March 31, 2026 by the June 29, 2026 due date due to a delay completing the Annual Report's financial statements. The company states it anticipates filing the Annual Report no later than the fifteenth calendar day following the prescribed filing date.

Insights

Corporate Governance Expert

Late 10-K filing flagged with a 12b-25 cure window.

The filing documents a procedural delay in completing financial statements for the fiscal year ended March 31, 2026 and invokes Rule 12b-25 relief. The company explicitly anticipates filing within the fifteen-calendar-day cure period.

Key dependencies include completion and review of audited financials and any accountant statements; subsequent filings will show whether the cure occurred within the stated window.

Key Figures

Fiscal year end: March 31, 2026 Original Form 10-K due date for smaller reporting companies: June 29, 2026 Cure period invoked: 15 calendar days

3 metrics

Fiscal year end March 31, 2026 Fiscal year ended

Original Form 10-K due date for smaller reporting companies June 29, 2026 Prescribed filing date

Cure period invoked 15 calendar days Anticipated filing within the 12b-25 cure window

Key Terms

Rule 12b-25, Form 10-K, smaller reporting companies

3 terms

Rule 12b-25 regulatory

"If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b)"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-K financial

"file its Annual Report on Form 10-K for the fiscal year ended March 31, 2026"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

smaller reporting companies regulatory

"the filing date applicable to smaller reporting companies due to a delay experienced by the Registrant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Antiaging Quantum Living (AAQL) file a Form 12b-25?

They state the company delayed completion of the Annual Report's financial statements for the fiscal year ended March 31, 2026. The Form 12b-25 notifies the SEC that the report could not be filed by June 29, 2026 due to that delay.

When does AAQL expect to file the delayed Form 10-K?

The company anticipates filing the Annual Report no later than the fifteenth calendar day following the prescribed filing date. That is the cure window provided under Rule 12b-25 for a late annual report when unreasonable effort or expense prevented timely filing.

Does the Form 12b-25 say whether other periodic reports are current for AAQL?

The notice includes a checkbox for whether other periodic reports have been filed and indicates compliance by marking the applicable response. The filing does not attach additional missing periodic-report identifications in the provided excerpt.

Who signed the Form 12b-25 for AAQL and when was it signed?

The notice is signed by Barry Wan, Chief Executive Officer, on June 29, 2026. The signature block appears immediately after the narrative and includes a telephone contact number for the registrant representative.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One):	☒ Form 10-K   ☐ Form 20-F   ☐ Form 11-K   ☐ Form 10-Q   ☐ Form N-SAR   ☐ Form N-CSR
	For Period Ended: March 31, 2026 ☐  Transition Report on Form 10-K ☐  Transition Report on Form 20-F ☐  Transition Report on Form 11-K ☐  Transition Report on Form 10-Q ☐  Transition Report on Form N-SAR For the Transition Period Ended: _______________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I – REGISTRANT INFORMATION

Antiaging Quantum Living Inc.

Full name of registrant:

N/A

Former name if applicable:

135-27 38th Ave #388

Address of principal executive office (Street and number):

Flushing, New York 11354

City, state and zip code

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

	(a)	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III – NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Antiaging Quantum Living Inc. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2026 (the “Annual Report”) by June 29, 2026, the filing date applicable to smaller reporting companies due to a delay experienced by the Registrant in completing its financial statement in the Annual Report. The Registrant anticipates that it will file the Annual Report no later than the fifteenth calendar day following the prescribed filing date.

PART IV – OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Barry Wan		+1		(929) 990-3255
(Name)		(Area Code)		(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
	☒ Yes ☐ No
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	☐ Yes ☒ No
	If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

2

Antiaging Quantum Living Inc.

(Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	June 29, 2026		By:	/s/ Barry Wan
			Name:	Barry Wan
			Title:	Chief Executive Officer

ATTENTION

Intentional misstatements or omissions of fact constitute Federal criminal violations. (See 18 U.S.C. 1001).

3